FDA approves rapid-acting inhaled insulin for children

Medical Xpress

FDA approves rapid-acting inhaled insulin for children

The U.S.

Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes. ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

FDA approves rapid-acting inhaled insulin for children

이 뉴스, 독자들은 어떻게 느꼈나요?

관련 뉴스

'science' 카테고리 뉴스

Researchers develop injectable device to control nerves without surgery

Mountainous landscapes store far more carbon than previously thought, new research shows

Trees may store less carbon than expected in the future

Medical Xpress의 다른 기사

Refined pseudo-germ-free mice reveal gut microbes' role in pancreatic cancer

Teens frequently encounter alcohol industry- and influencer-generated alcohol content on social media platforms

Stem cell embryo models could unlock infertility clues beyond 14-day research limit